Peer-Reviewed Publication
Science2026;eadv8291.June 11, 2026Journal Article

Chemically induced skin tumors arise from long-lived stem cells of the upper hair follicle.

Eve Kandyba1, Arnaud Jabouille1, Ferriol Calvet2, Yun Rose Li1,3,4, Andrea Curtabbi1, Diana Cristea1, Joyce Shin1, Reyno Delrosario1, Jonathan Anzules3, Di Wu1, David Quigley1, Mark Taylor1, Camila Zanette5, Fang Yin Lo5,6, Jacob Higgins5, Jesse Salk5, Nuria Lopez-Bigas2,7,8,9, Allan Balmain1
1Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
2Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
3Department of Radiation Oncology and Cancer Genetics and Epigenetics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
4Division of Bioinnovation and Genome Sciences, Translational Genomics Research Institute, Phoenix, AZ, USA.
5TwinStrand Biosciences, Seattle, WA, USA.
6Generate Biomedicines, Somerville, MA, USA.
7Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
8Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
9Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

Abstract

The identification of the cancer cell of origin is a fundamental question in cancer biology. We used fluorescent lineage tracing of independent mouse skin stem cell populations, single cell transcriptomics, and Duplex sequencing, to identify the origin of chemically induced skin tumors. Tumors arose predominantly from Lgr6+ and / or Lrig1+ stem cells of the upper hair follicle, but only very rarel…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.